First Manhattan’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-171
Closed 1472
2018
Q2
$0 Hold
171
﹤0.01% 1455
2018
Q1
$0 Hold
171
﹤0.01% 1512
2017
Q4
$0 Hold
171
﹤0.01% 1557
2017
Q3
$0 Hold
171
﹤0.01% 1531
2017
Q2
$0 Hold
171
﹤0.01% 1505
2017
Q1
$0 Hold
171
﹤0.01% 1482
2016
Q4
$0 Hold
171
﹤0.01% 1486
2016
Q3
$0 Hold
171
﹤0.01% 1502
2016
Q2
$0 Hold
171
﹤0.01% 1552
2016
Q1
$0 Hold
171
﹤0.01% 1483
2015
Q4
$0 Hold
171
﹤0.01% 1514
2015
Q3
$0 Hold
171
﹤0.01% 1509
2015
Q2
$0 Hold
171
﹤0.01% 1523
2015
Q1
$0 Hold
171
﹤0.01% 1545
2014
Q4
$0 Buy
+171
New +$185 ﹤0.01% 1561

First Manhattan's BTX.WS Position: Q3 2018 in Review

First Manhattan sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 171 shares.

First Manhattan first reported a position in BTX.WS in Q4 2014 and held it in 15 quarters. The position peaked at $0 in Q2 2018. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • First Manhattan reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • First Manhattan sold 171 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018.
  • First Manhattan first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 15 quarters.
  • First Manhattan's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q2 2018.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on First Manhattan's 13F filing for Q3 2018, filed 15 Oct 2018.